Peer Review reports
From: MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
| Original Submission | ||
|---|---|---|
| 19 Sep 2010 | Submitted | Original manuscript |
| 15 Oct 2010 | Reviewed | Reviewer Report - Frederic Blanchard |
| 26 Jan 2011 | Reviewed | Reviewer Report - frederique BRAUN |
| 18 Mar 2011 | Author responded | Author comments - Hege Ohnstad |
| Resubmission - Version 2 | ||
| 18 Mar 2011 | Submitted | Manuscript version 2 |
| 24 Mar 2011 | Reviewed | Reviewer Report - Frederic Blanchard |
| 31 Mar 2011 | Reviewed | Reviewer Report - frederique BRAUN |
| 19 Apr 2011 | Author responded | Author comments - Hege Ohnstad |
| Resubmission - Version 3 | ||
| 19 Apr 2011 | Submitted | Manuscript version 3 |
| 11 May 2011 | Author responded | Author comments - Hege Ohnstad |
| Resubmission - Version 4 | ||
| 11 May 2011 | Submitted | Manuscript version 4 |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| 20 May 2011 | Author responded | Author comments - Hege Ohnstad |
| Resubmission - Version 6 | ||
| 20 May 2011 | Submitted | Manuscript version 6 |
| Publishing | ||
| 30 May 2011 | Editorially accepted | |
| 30 May 2011 | Article published | 10.1186/1471-2407-11-211 |
You can find further information about peer review here.